(1)
Kadhim, A. A.; Jamal, M. Y.; Karim, A. K. Natalizumab Immunogenicity in Multiple Sclerosis: Evaluating Antibody Development and Clinical Outcomes in an Iraqi Cohort. Al-Rafidain J Med Sci 2025, 9, 83-89.